Global Health Limited (“Medanta”), one of the largest private multi-specialty tertiary care providers in the North & East regions of India, on Wednesday, 25 March 2026, announced that,

The Company has signed a definitive agreement with Shripal Hospitality LLP & Others to set up a 400-bed multi-specialty hospital in the centre of Varanasi, Uttar Pradesh, India. Source: BSE

Important Details

According to the information available on the exchange, the Board of Directors of Medanta, at its meeting held today, approved the execution of definitive agreements (Built-to-Suit and lease arrangement) with Shripal Hospitality and others to establish a state-of-the-art super specialty hospital in Varanasi.

The proposed hospital will be developed on strategically located freehold land in central Varanasi and is expected to cater to a population of over 4 million in the city and its surrounding regions.

The hospital will deliver advanced clinical care through a combination of (1) world-class medical expertise, (2) cutting-edge technology, and (3) a comprehensive multi-specialty offering, a company spokesperson added.

Total Investment

The Company is required to make investments in deposits, Interior fit-outs, MEP, medical equipment, and any other associated capex.

The total investment made by the Company is estimated at INR 550 crores.

The funding will be a combination of internal accruals and debt financing, as per the company officials.

Duration

The proposed construction of the hospital is expected to be completed within 4 years, subject to necessary customary and statutory approvals.

Medanta To Set Up A 400-Bed Hospital In Varanasi

Management Speech –

Commenting on the latest development, Dr. Naresh Trehan, Chairman and Managing Director of the company, shared,

We are pleased to announce our plans to establish a 400-bed multi-specialty hospital in the heart of Varanasi, a city of deep cultural and spiritual significance.

This expansion reflects Medanta’s commitment to enhancing access to advanced healthcare in a densely populated region, while delivering high-quality, patient-centric care with compassion, in line with our philosophy, Har Ek Jaan Anmol.

The proposed facility will not only address the growing demand for tertiary care in Varanasi but will also serve as a key healthcare hub for Eastern Uttar Pradesh.

With this addition, Medanta will further strengthen its presence in the State, building on the strong foundation established by our hospitals in Lucknow and Noida, and continue to serve the evolving healthcare needs of the region.

Refer to Medanta Hospital News for further information.

Market Cap: The company’s market capitalization is ₹27,200 Cr.

Technical: The stock is currently trading below its 20-day, 50-day, 100-day, and 200-day SMA.

Price Performance: The stock has fell 19% over the past one year, declined 14.75% year to date, declined 15% over the last three months, and declined 12.50% in the past one month.

ALSO READ: Happy Forgings Limited (Value Pick Stock March 2026)

Disclaimer: The contents and data presented here are just for your information & personal use only. While much effort is made to provide the information, I (Vishal Dalwadi) or “FinBlab” do not guarantee the accuracy, correctness, completeness or reliability of any information or data displayed herein and shall not be held responsible.

The post Medanta To Set Up A 400-Bed Hospital In Varanasi appeared first on Upcoming ipos: Latest news on stocks, economy & finance.

Global Health: History

Global Health is founded by Dr. Naresh Trehan – a world-renowned cardiovascular and cardiothoracic surgeon.

He has been awarded the prestigious Padma Bhushan (the third highest civilian awards in India) and the Padma Shri (the fourth highest civilian awards in India), and the BC Roy Award, in recognition of his distinguished contribution to medicine.

He has been rewarded a special award for outstanding contributions as ‘Indian Father of Cardiac Surgery’ by the American Association of Cardiologists of Indian Origin.

Global Health: Profile

Global Health Limited (Medanta) is established with the sole mission to deliver world-class, holistic and affordable healthcare and to build a dynamic institution that focuses on the development of people and new knowledge.

The Company is one of the largest private multi-speciality tertiary care providers operating in the East and North regions of India in terms of bed capacity and operating revenues (amongst the players that operate in the North and East regions of India)

The company has Key Specialities in –

• Cardiology and cardiac science,
• Digestive and hepatobiliary sciences,
• Liver transplant,
• Neurosciences,
• Oncology,
• Orthopaedics,
• Kidney related diseases, and
• Urology

Global Health: Network

Global Health has a network of 5 hospitals currently in operation (Ranchi, Patna, Lucknow, Indore, and Gurugram) under the “Medanta” brand.

Promoters

Dr Naresh Trehan

IPO DETAILS

Dates = 3 Nov 2022 to 07 Nov 2022

Face Value (FV) = INR 2

Issue Price / Floor Price = INR 319 to INR 336

Application per Share = INR 336

Minimum Investment Amount = INR 14784

Minimum Bid = 44 Shares

Maximum Shares for Retail = N.A.

FINANCIALS

Conclusion

Considering the company’s financial parameters, FinBlab recommends SUBSCRIBE ratings on global health limited ipo

Also Read

Stocks Where Fiis Have Increased Stake In Q2 Fy23

bikaji foods ipo

Fusion Micro Finance Limited IPO

Disclaimer: The contents and data presented here are just for your information & personal use only. While much effort is made to provide the information, I ( Vishal Dalwadi ) or “FinBlab” do not guarantee the accuracy, correctness, completeness or reliability of any information or data displayed herein and shall not be held responsible.

The post Global Health Limited IPO – Review appeared first on Upcoming ipos: Latest news on stocks, economy & finance.